Over half of UK adults over the age of 65 live with two or more long-term health conditions—commonly known as multimorbidity. People living with multimorbidity not only have a shorter life expectancy, but they may also ...
Jan 14, 2022
1
29
Researchers in Japan and the United States have found SARS-CoV-2 can knock out an important molecular pathway linked to an immune complex called MHC class I. The finding should help scientists better understand how COVID-19 ...
Dec 7, 2021
1
174
A research team led by a scholar from City University of Hong Kong (CityU) has recently developed a novel artificial intelligence (AI) framework that can make synergistic anti-cancer drug combination predictions on both the ...
Dec 1, 2021
0
3
Just in the nick of time for the holidays, as families prepare to gather again in record numbers, a Centers for Disease Control and Prevention (CDC) panel today unanimously endorsed Pfizer and Moderna's COVID-19 booster shots ...
Nov 22, 2021
0
1
Much progress has been made on the development of vaccines aiming at triggering human immunity to SARS-CoV-2, the virus that causes COVID-19. In addition, researchers at Baylor College of Medicine are involved in the development ...
Aug 31, 2021
0
150
A cancer drug repurposed to treat malaria has been shown to be nearly 100% effective in helping defeat the disease in just three days, according to the results of a Phase 2 clinical trial.
Aug 27, 2021
0
555
Drug delivery plays an important role in the treatment of diseases. Matching a specific drug molecule with the right delivery route optimizes therapeutic performance and minimizes side effects. Associate Professor Matthias ...
Aug 19, 2021
0
0
Healthy adult brains are endowed with a vast number of synapses, structures that relay signals across nerve cells to enable communications, information processing and storage throughout the nervous system. Apart from dynamic ...
Aug 18, 2021
0
224
It usually takes 10 to 15 years to develop a new drug, and they cost around US$2.6 billion each. Because it's difficult to predict how a drug candidate will interact with human cells, many drugs never pass clinical trials. ...
Jul 27, 2021
0
18
Writing in the July 12, 2021 online issue of Nature Communications, researchers at University of California San Diego School of Medicine describe a new approach that uses machine learning to hunt for disease targets and then ...
Jul 12, 2021
0
16
